drugset / Trial / NCT00475969

Duloxetine vs Placebo in the Treatment of General Anxiety

NCT00475969

Phase 3 Completed 327 enrolled Eli Lilly and Company Boehringer Ingelheim · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

To see if duloxetine 60 to 120 mg once daily (QD) is better than placebo in the treatment of generalized anxiety disorder (GAD).

Timeline

Start
2004-08
Primary completion
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 60 mg
Subject Duloxetine Small molecule 120 mg